v3.25.4
Segments of Business and Geographic Areas - Schedule of Segment Reporting Information (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 28, 2025
Dec. 29, 2024
Dec. 31, 2023
Segment Reporting Information [Line Items]      
Earnings before provision for taxes on income $ 32,581 $ 16,687 $ 15,062
Identifiable Assets 199,210 180,104  
Additions to Property, Plant & Equipment 4,832 4,424 4,543
Depreciation and Amortization 7,503 7,339 7,486
Equity securities, FV-NI, gain (loss)   400 400
Proceeds from Royalties Received   300  
Restructuring 228 234 489
Yellow Jersey Therapeutics      
Segment Reporting Information [Line Items]      
Payments to Acquire in Process Research and Development 1,250 1,250  
Baby Powder | Talc      
Segment Reporting Information [Line Items]      
Loss contingency, loss in period   5,100 7,000
Talc      
Segment Reporting Information [Line Items]      
Reversal of fee expense 7,000    
Innovative Medicine      
Segment Reporting Information [Line Items]      
Restructuring   102  
Acquisition related costs 400    
Gain (loss) on divestiture     (200)
Innovative Medicine | Momenta      
Segment Reporting Information [Line Items]      
Impairment of intangible assets, excluding goodwill   200 200
MedTech      
Segment Reporting Information [Line Items]      
Acquisition related costs 200 1,000 200
Gain (loss) on divestiture   200  
Regulation charge   200 300
Litigation expense 900 300  
MedTech | Laminar      
Segment Reporting Information [Line Items]      
Payments to Acquire in Process Research and Development     400
MedTech | V-Wave Ltd.      
Segment Reporting Information [Line Items]      
Payments to Acquire in Process Research and Development   500  
Segments Total      
Segment Reporting Information [Line Items]      
Identifiable Assets 164,539 141,392  
Additions to Property, Plant & Equipment 4,577 4,153 4,025
Depreciation and Amortization 7,262 6,997 6,790
Consumer Health      
Segment Reporting Information [Line Items]      
Additions to Property, Plant & Equipment 0 0 162
Depreciation and Amortization 0 0 383
Consumer Health | Talc      
Segment Reporting Information [Line Items]      
Reversal of fee expense 7,000    
Litigation expense   5,100 7,000
Operating Segments      
Segment Reporting Information [Line Items]      
Earnings before provision for taxes on income 26,379 22,659 22,915
Restructuring 512 269 798
Operating Segments | Innovative Medicine      
Segment Reporting Information [Line Items]      
Earnings before provision for taxes on income 22,266 18,919 18,246
Identifiable Assets 78,057 57,070  
Additions to Property, Plant & Equipment 2,076 1,710 1,653
Depreciation and Amortization 3,772 3,760 3,847
Restructuring 0 102 479
Supplies expense   100 700
Operating Segments | MedTech      
Segment Reporting Information [Line Items]      
Earnings before provision for taxes on income 4,113 3,740 4,669
Identifiable Assets 86,482 84,322  
Additions to Property, Plant & Equipment 2,501 2,443 2,372
Depreciation and Amortization 3,490 3,237 2,943
Restructuring 500 167 319
Segment Reporting, Reconciling Item, Corporate Nonsegment | General Corporate      
Segment Reporting Information [Line Items]      
Identifiable Assets 34,671 38,712  
Additions to Property, Plant & Equipment 255 271 356
Depreciation and Amortization $ 241 $ 342 $ 313